Computational and Experimental Verification of Cabozantinib to Inhibit DNA Damage Repair in Liver Cancer

ABSTRACT: The proteomics study of cabozantinib-treated hepatocellular carcinoma cells.

ORGANISM(S): Homo Sapiens

SUBMITTER: Liping Liu  

PROVIDER: PXD070703 | iProX | Thu Nov 13 00:00:00 GMT 2025

REPOSITORIES: iProX